SK204692A3 - N-phenylthiourea derivatives and their pharmaceutical using - Google Patents

N-phenylthiourea derivatives and their pharmaceutical using Download PDF

Info

Publication number
SK204692A3
SK204692A3 SK2046-92A SK204692A SK204692A3 SK 204692 A3 SK204692 A3 SK 204692A3 SK 204692 A SK204692 A SK 204692A SK 204692 A3 SK204692 A3 SK 204692A3
Authority
SK
Slovakia
Prior art keywords
compound
formula
compounds
apo
cholesterol
Prior art date
Application number
SK2046-92A
Other languages
English (en)
Slovak (sk)
Inventor
Gary Mark Coppola
Robert E Damon
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SK204692A3 publication Critical patent/SK204692A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
SK2046-92A 1991-07-01 1992-06-30 N-phenylthiourea derivatives and their pharmaceutical using SK204692A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72400191A 1991-07-01 1991-07-01

Publications (1)

Publication Number Publication Date
SK204692A3 true SK204692A3 (en) 1995-02-08

Family

ID=24908548

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2046-92A SK204692A3 (en) 1991-07-01 1992-06-30 N-phenylthiourea derivatives and their pharmaceutical using

Country Status (24)

Country Link
EP (1) EP0528146B1 (hu)
JP (1) JPH05221959A (hu)
KR (1) KR930002311A (hu)
AT (1) ATE134364T1 (hu)
AU (1) AU657141B2 (hu)
CA (1) CA2072704A1 (hu)
CZ (1) CZ204692A3 (hu)
DE (1) DE69208408T2 (hu)
DK (1) DK0528146T3 (hu)
ES (1) ES2083625T3 (hu)
FI (1) FI923033A (hu)
GR (1) GR3019785T3 (hu)
HK (1) HK73196A (hu)
HU (1) HUT62558A (hu)
IE (1) IE73488B1 (hu)
IL (1) IL102355A0 (hu)
MX (1) MX9203838A (hu)
NO (1) NO922564L (hu)
NZ (1) NZ243352A (hu)
RO (1) RO111933B1 (hu)
RU (1) RU2087467C1 (hu)
SK (1) SK204692A3 (hu)
TW (1) TW213448B (hu)
ZA (1) ZA924823B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2271728A1 (en) * 1996-11-14 1998-05-22 American Home Products Corporation Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents
WO1998033775A1 (en) * 1997-02-03 1998-08-06 American Home Products Corporation 2-substituted-1-acyl-1,2-dihydroquinoline derivatives to increase hdl-cholesterol level
AU7498298A (en) * 1997-06-16 1999-01-04 American Home Products Corporation Elevation of hdl cholesterol by n-{2-{ (aminothioxomethyl)hydrazono} -2-arylethyl}amides
US6011053A (en) * 1997-08-01 2000-01-04 American Home Products Corporation Substituted indole-1-carbothioic acid amides as novel antiatherosclerotic agents
TW415942B (en) * 1997-09-03 2000-12-21 American Home Prod Novel substituted 1-aryl-3-heteroaryl-thioureas and substituted 1-aryl-3-heteroaryl-isothioureas as antiatherosclerotic agents
AU9211098A (en) * 1997-09-03 1999-03-22 American Home Products Corporation Thiourea for increasing hdl-cholesterol levels, which are useful as anti-atherosclerotic agents
WO1999011618A1 (en) * 1997-09-03 1999-03-11 American Home Products Corporation Substituted indole-1-carbothioic acid amides as novel antiatherosclerotic agents
US6455566B1 (en) 1997-09-03 2002-09-24 Wyeth Substituted 1-aryl-3-heteroaryl-thioureas (or isothioureas) as antiatherosclerotic agents
DE10017881A1 (de) * 2000-04-11 2001-10-25 Bayer Ag Wirkstoffkombinationen mit insektiziden und akariziden Eigenschaften
WO2003024441A1 (fr) 2001-09-14 2003-03-27 Shionogi & Co., Ltd. Nouvelle utilisation de composes tricycliques
US20030153596A1 (en) 2000-08-21 2003-08-14 Suh Young Ger Novel thiourea derivatives and the pharmaceutical compositions containing the same
WO2002016318A1 (en) 2000-08-21 2002-02-28 Pacific Corporation Novel thiourea derivatives and the pharmaceutical compositions containing the same
US6472430B2 (en) 2000-10-02 2002-10-29 Hassan M. Elokdah Amino thioxomethyl amino oxyacetic acid derivatives
US7429593B2 (en) 2001-09-14 2008-09-30 Shionogi & Co., Ltd. Utilities of amide compounds
US8124625B2 (en) 2001-09-14 2012-02-28 Shionogi & Co., Ltd. Method of enhancing the expression of apolipoprotein AI using olefin derivatives
ES2362770B1 (es) * 2009-12-24 2012-05-22 Universidad De Sevilla Uso de compuesto n-fenil-n'-(3-metil-2-butenil)tiourea para la elaboración de medicamentos destinados al tratamiento de la encefalopatía hepática.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950537A (en) * 1973-06-29 1976-04-13 Rohm And Haas Company Gastrointestinally active thioureas
IL67417A (en) * 1982-01-26 1989-10-31 American Cyanamid Co Antiatherosclerotic substituted ureas,process for their preparation and pharmaceutical compositions containing them
DE3861988D1 (en) * 1987-07-02 1991-04-18 Warner Lambert Co N-((2,6-disubstituierte)-phenyl)-harnstoff und -carbamat-inhibitoren der acyl-coenzym a:cholesterol-acyltransferase.
US5116848A (en) * 1988-03-30 1992-05-26 Warner-Lambert Company N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
GB8908063D0 (en) * 1989-04-11 1989-05-24 Beecham Group Plc Novel compounds
JPH0395153A (ja) * 1989-06-15 1991-04-19 Mitsubishi Kasei Corp ジフェニル尿素誘導体

Also Published As

Publication number Publication date
HUT62558A (en) 1993-05-28
FI923033A (fi) 1993-01-02
TW213448B (hu) 1993-09-21
RO111933B1 (ro) 1997-03-31
KR930002311A (ko) 1993-02-22
ES2083625T3 (es) 1996-04-16
IL102355A0 (en) 1993-01-14
RU2087467C1 (ru) 1997-08-20
ATE134364T1 (de) 1996-03-15
FI923033A0 (fi) 1992-06-30
AU657141B2 (en) 1995-03-02
DK0528146T3 (da) 1996-05-06
ZA924823B (en) 1993-12-29
DE69208408D1 (de) 1996-03-28
AU1867792A (en) 1993-01-07
DE69208408T2 (de) 1996-07-18
CA2072704A1 (en) 1993-01-02
EP0528146B1 (en) 1996-02-21
NO922564D0 (no) 1992-06-29
HK73196A (en) 1996-05-03
MX9203838A (es) 1993-01-01
NZ243352A (en) 1995-02-24
IE73488B1 (en) 1997-06-04
JPH05221959A (ja) 1993-08-31
CZ204692A3 (en) 1993-01-13
GR3019785T3 (en) 1996-07-31
EP0528146A1 (en) 1993-02-24
NO922564L (no) 1993-01-04
HU9202047D0 (en) 1992-09-28
IE922132A1 (en) 1993-01-13

Similar Documents

Publication Publication Date Title
SK204692A3 (en) N-phenylthiourea derivatives and their pharmaceutical using
Heath et al. Glycation-induced inactivation of malate dehydrogenase protection by aspirin and a lens molecular chaperone, α-crystallin
EP0497928A1 (en) Yeast-derived epidermal growth factor/urogastrone-like products
Bendich et al. Immunochemical Studies on Blood Groups. V. Further Characterization of Blood Group A and O Substances from Individual Hog Stomachs1a
CS655889A3 (en) Anti-atherosclerotic active compounds, pharmaceuticals containing suchcompounds and process for preparing thereof
JP2001525408A (ja) Ｓ−オキシドおよびｓ，ｓ−ジオキシドテトラヒドロチオピランフェニルオキサゾリジノン
Bowman et al. A Novel Phospholipase A2Activity in Saliva of the Lone Star Tick, Amblyomma americanum (L.)
EP0363041A1 (en) Monoclonal antibody to morphine, preparation of monoclonal antibody, assaying kit and assaying method of morphine
JPH02502017A (ja) アポａｉの定量のための診断法及び診断システム
EP0043285B2 (en) Method for determination of valproic acid and reagents therein
Bartholomaeus et al. Inhibition of rat liver cytosolic glutathione S-transferase by silybin
US4946963A (en) Compounds for the control of hyperlipidemia using N-substituted isoxazolidine-3,5-diones
JPS61218529A (ja) モノクローナル抗‐アルフア‐アミラーゼ‐抗体、その収得法及びこれを含有する真性糖尿病治療剤
Takeda et al. Crystallization and preliminary X-ray diffraction analysis of an acidic phospholipase A2 complexed with p-bromophenacyl bromide and α-tocopherol inhibitors at 1.9-and 1.45-Å resolution
EP0359112A2 (en) Carbazate derivatives, their production and use
PL167376B1 (pl) Sposób wytwarzania pochodnych N-fenylotiomocznika
EP0175005A1 (en) 5,6,7-Quinoline carbamates
US4999366A (en) Isoxazolidine-3,5-diones, pharmaceutical compositions and method of treatment
CN115368352B (zh) 一种葡萄糖激酶激动剂及其制备方法和应用
RU2034845C1 (ru) 5- ИЛИ 6-ЗАМЕЩЕННЫЕ СЛОЖНЫЕ ЭФИРЫ β -КАРБОЛИН-3-КАРБОНОВОЙ КИСЛОТЫ, ОБЛАДАЮЩИЕ ПСИХОТРОПНОЙ АКТИВНОСТЬЮ, И ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ ДЛЯ ЛЕЧЕНИЯ ПСИХОТРОПНЫХ ЗАБОЛЕВАНИЙ
Hillman Mutant analysis of glyceraldehyde 3-phosphate dehydrogenase in Escherichia coli
EP0211368B1 (en) Monoclonal anti-asialo GM1 antibody
Nakao et al. Characterization of the classical complement pathway of rainbow trout
US4416876A (en) Para-amino benzoic and phenylacetic acid derivatives
US5861517A (en) 2-thioxo-imidazolidin-4-one derivatives